| 6 | 1/1 | 返回列表 |
| 查看: 3510 | 回復: 5 | |||
| 【有獎交流】積極回復本帖子,參與交流,就有機會分得作者 vnyh3993 的 46 個金幣 ,回帖就立即獲得 1 個金幣,每人有 1 次機會 | |||
[交流]
IgY-Technology英文專著在Springer出版
|
|||
|
IgY-Technology: Production and Application of Egg Yolk Antibodies: Basic Knowledge for a Successful Practice 近日,IgY抗體技術專著(IgY-Technology: Production and Application of Egg Yolk Antibodies: Basic Knowledge for a Successful Practice, Springer Nature Group, Switzerland. 2021. ISBN: 978-3-030-72686-7. https://www.springer.com/gp/book/9783030726867#aboutBook)在Springer出版社出版,該書是全球范圍內第一部針對IgY抗體技術的系統(tǒng)性英文學術專著,由張小鶯教授領銜主編,聯(lián)合近二十個國家的四十多位學者歷時多年編撰而成。 專著鏈接:https://www.springer.com/gp/book/9783030726867#aboutBook 該專著共18章,系統(tǒng)性的回顧和總結了IgY抗體技術的發(fā)展歷程、技術特點和發(fā)展前沿,涉及理論基礎、技術方法學及生物醫(yī)藥領域的研發(fā)應用。專著覆蓋了IgY技術相關的各個領域,如進化視野下的IgY分子機制、受體與轉運機制、免疫技術、IgY抗體的不同提取純化策略、儲存穩(wěn)定性、工業(yè)化生產(chǎn)、在人類和獸醫(yī)領域中的應用、IgY遞送策略、IgY基因工程抗體制備、轉基因動物開發(fā)、IgY產(chǎn)品報批及產(chǎn)業(yè)化,技術局限與創(chuàng)新等。 近年來,IgY抗體技術(卵黃抗體技術)不斷發(fā)展,具備了相對完備統(tǒng)一的技術模式;不斷與現(xiàn)代生物學技術相結合,拓展技術自生的內涵和外延;相關產(chǎn)品在世界范圍內不斷報批問世,形成了一定的產(chǎn)業(yè)基礎。 據(jù)悉,科學出版社將與張小鶯教授團隊合作,在2011年中文版的基礎上,適時推出IgY抗體技術中文第二版,以供中國讀者和研究人員參考、交流。 圖書信息 This first edited Volume on IgY-Technology, addresses the historical and dynamic development of IgY-applications. The authors cover the biological basis and theoretical context, methodological guidance, and applications of IgY-Technology. A focus is laid on the use of IgY-antibodies for prophylactic/therapeutic purposes in human and veterinary medicine. Aside from applications, the chapters also offer an evolutionary understanding of the IgY molecule, IgY receptors and practical prerequisites to produce IgY-antibodies. Guidance is given for every step of the process. Starting with an introduction to hens as a model species and including hen husbandry, hen egg-laying capacity and total IgY outcomes. Readers will also learn about immunization techniques, the advantages and limitations of different IgY extraction methods, as well as storage stability of the final product. The last part of the volume highlights hands-on aspects of applications, such as IgY delivery strategies, new methods to produce monoclonal IgY-antibodies or production of functional IgY fragments by phage-display as well as commercial exploitation of the technology. Thus, this book is a valuable resource and guide for Scientists, Clinicians and Health Product Developers in both human and veterinary medicine. 主編信息 Prof. Dr. Xiaoying ZHANG, PhD in Pharmacology (Charité Medical University Berlin), Distinguished Professor at Shaanxi Univ. of Technology (2019-present); Senior Researcher at CBMA, Univ. of Minho, Portugal (2016-present); Professor (Adjunct) at Univ. of Guelph, Canada (2017-present); Professor at Northwest Agricultural & Forestry Univ., China (2008-2018). He has been dedicated to the development, popularisation and application of IgY Technology. Ricardo S. Vieira-Pires is an Assistant Investigator at the Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Portugal. He obtained his PhD in Structural Biology (2008) at University Joseph Fourier, Grenoble, France. He is head of the Structural Biotechnology Group that studies proteins and molecular assemblies involved in key processes of bacterial and viral infectious diseases. He is particularly interested in targeting microbial surface-exposed virulent factors using antibodies. He is head of the CNC – Avian Technological Unit that explores bird immune repertoires for antibody discovery. He is engaged with academic and industry partners promoting IgY Technology-based solutions for human and veterinary medicine. Patricia M. Morgan is an Emerita Senior Lecturer at the National University of Ireland Galway (NUI Galway). Having been awarded a PhD in Biochemistry at NUI Galway, she undertook post-doctoral research at the University of Wisconsin-Madison, USA in the areas of reproductive biology and endocrinology. She has held senior positions at NUI Galway as Dean of the College of Science and Dean of Graduate Studies. In these posts, she has championed research developments within the University particularly in the areas of Biotechnology and Innovation. She has served on various national committees promoting science and is an advocate for the public understanding of science and the promotion of inclusion and diversity in academia. Rüdiger Schade started his scientific career at the Institute of Pharmacology, Charité – Universitätsmedizin in Berlin, Germany, in 1976. Since the early 1990’s, his research has been strongly focused on the development, production and application of IgY antibodies. His contributions significantly influenced the field of IgY-technology and promoted the application of this technology worldwide, particularly in Latin-America. In acknowledgement of his research efforts, he received the FISEA prize – the International Foundation for the Substitution of Animal Experimentation, Luxemburg - in 1997. |
» 搶金幣啦!回帖就可以得到:
+1/897
+5/765
+1/90
+1/80
+1/80
+1/69
+2/46
+1/44
+2/42
+1/36
+1/35
+1/22
+1/17
+1/14
+1/10
+1/10
+1/6
+1/3
+1/1
+1/1
| 6 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 085600 材料與化工 295 求調劑 +6 | dream…… 2026-03-10 | 6/300 |
|
|---|---|---|---|---|
|
[考研] 一志愿江南大學085701環(huán)境工程專碩總分287求調劑 +3 | 18266118446 2026-03-09 | 3/150 |
|
|
[考研] A區(qū)一本交叉課題組,低分調劑,招收機械電子信息通信等交叉方向 +56 | lisimayy 2026-03-04 | 73/3650 |
|
|
[考研] 265求調劑 +7 | 小木蟲085600 2026-03-09 | 10/500 |
|
|
[考研] 315食品工程求調劑 +3 | Oreov0 2026-03-06 | 6/300 |
|
|
[考研] 0703化學調劑 +7 | 小奶蒼 2026-03-07 | 7/350 |
|
|
[考研]
|
簡木ChuFront 2026-03-09 | 4/200 |
|
|
[考研] 數(shù)二英二309分請求調劑 +3 | dtdxzxx 2026-03-09 | 4/200 |
|
|
[考研] 一志愿山東大學,總分327,英語二79,有論文,有競賽,已過四六級 +3 | 木木目目1 2026-03-09 | 3/150 |
|
|
[考研] 085701環(huán)境工程專碩求調劑 +5 | 幼稚園大班打手 2026-03-08 | 5/250 |
|
|
[考研] 0856材料與化工290求調劑 +7 | Nebulala 2026-03-08 | 8/400 |
|
|
[考研] 理學287分求調劑 +4 | 看看我. 2026-03-05 | 4/200 |
|
|
[考研] 347求調劑 +4 | 浮云滿足 2026-03-07 | 4/200 |
|
|
[考研] 276求調劑 本科天津工業(yè)大學 一志愿北京化工大學0855 +4 | 路lyh123 2026-03-06 | 6/300 |
|
|
[考研] 紡織、生物、化學、材料等專業(yè) +3 | Eember. 2026-03-05 | 7/350 |
|
|
[考研] 304求調劑 +3 | 曼殊2266 2026-03-04 | 3/150 |
|
|
[考研] 322分 085600求調劑,有互聯(lián)網(wǎng)+國金及主持省級大創(chuàng)經(jīng)歷 +6 | 熊境喆 2026-03-04 | 6/300 |
|
|
[考研] 0703化學 一志愿東北大學 279分求調劑 +4 | 聶樂平 2026-03-03 | 4/200 |
|
|
[考研] 295求調劑 +6 | 等春來, 2026-03-04 | 6/300 |
|
|
[考研] 293求調劑 +4 | 是樂渝哇 2026-03-03 | 4/200 |
|